'How Does It Feel to Be Number One?' First Patient Receives Biogen's Alzheimer's Drug in New Trial

Being Patient advisor Jeff Borghoff, who was diagnosed with early onset Alzheimer's, was the first patient in the world today to receive a dose of Biogen's Alzheimer's drug, aducanumab, in the new trial. Find out more here: https://www.beingpatient.com/first-pa... Our mission is to give people impacted by dementia a better resource and connection to experts at the forefront of research. Our founder Deborah Kan funded Being Patient solely with her own savings to understand if people would value such a resource. Our audience has grown so rapidly, we have exciting plans for the future to enhance our coverage even further but we need your help. Please consider making a contribution to help fund Being Patient's editorial costs. We employ a team of journalists to give you the best possible information on dementia and brain health without bias. To catch our Brain Talks live, join our Facebook page:   / beingpatientalzheimers   For the latest news on dementia research and lifestyle tips, visit our site: https://www.beingpatient.com/